CTI BioPharma Corp. CTIC
Set alert
9.10 0.00 0.00%
As of Jun 23, 3:58 PM ET
9.09 Day range 9.10
52-week range unavailable
- Open
- 9.10
- Prev close
- 9.10
- Mkt cap
- 1.20B
- Vol
- 5.56M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 9.09
- High
- 9.10
- Forward P/E
- 101.00
- Beta
- 0.83
- Short ratio
- 1.08
- Inst. own
- 83.29%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 14, 2023
- 50-d avg
- 7.63
- 200-d avg
- 5.87
- 1y target
- 10.37
Analyst view
Consensus: buy
Buy
Price target (mean) 10.37 +14.0% upside
Now 9.10
- Target (low)
- 9.00
- Target (mean)
- 10.37
- Target (high)
- 13.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy1
- Buy0
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
- 1 month ago 8
- 2 months ago 8
- 3 months ago 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.08 | -0.09 – -0.08 | -0.21 | +61.9% | 26.57M | +115.5% | 3 |
| Next quarter | -0.07 | -0.07 – -0.07 | -0.13 | +46.2% | 29.88M | +74.0% | 3 |
| Current year | -0.31 | -0.32 – -0.29 | -0.81 | +61.7% | 114.76M | +112.7% | 3 |
| Next year | 0.09 | -0.08 – 0.29 | -0.31 | +129.0% | 183.63M | +60.0% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 24, 2023 | JMP Securities | Maintained | — | Market Perform |
| May 16, 2023 | SVB Leerink | Downgrade | Outperform | Market Perform |
| May 15, 2023 | Stifel | Downgrade | Buy | Hold |
| May 11, 2023 | JMP Securities | Downgrade | Market Outperform | Market Perform |
| May 11, 2023 | Needham | Downgrade | Buy | Hold |
| Apr 19, 2023 | Needham | Reiterated | — | Buy |
| Apr 17, 2023 | TD Cowen | Maintained | — | Outperform |
| Mar 7, 2023 | JMP Securities | Reiterated | — | Market Outperform |
| Mar 6, 2023 | Needham | Reiterated | — | Buy |
| Feb 6, 2023 | JMP Securities | Reiterated | — | Market Outperform |
| Oct 17, 2022 | SVB Leerink | Initiated | — | Outperform |
| Sep 1, 2022 | Jefferies | Initiated | — | Buy |
| Aug 9, 2022 | JMP Securities | Maintained | — | Market Outperform |
| Aug 9, 2022 | Needham | Maintained | — | Buy |
| Jul 7, 2022 | Cowen & Co. | Initiated | — | Outperform |
| Mar 2, 2022 | JMP Securities | Maintained | — | Market Outperform |
| Mar 2, 2022 | Needham | Maintained | — | Buy |
| Dec 1, 2021 | Needham | Maintained | — | Buy |
| Aug 9, 2021 | BTIG | Initiated | — | Buy |
| May 6, 2021 | Stifel | Initiated | — | Buy |
| Oct 23, 2020 | Brookline Capital | Initiated | — | Buy |
| Sep 30, 2020 | Needham | Maintained | — | Buy |
| Mar 5, 2019 | Lake Street | Initiated | — | Buy |
| Mar 7, 2018 | JMP Securities | Initiated | — | Outperform |
| Feb 23, 2018 | Oppenheimer | Initiated | — | Outperform |
| Sep 12, 2017 | Jefferies | Initiated | — | Buy |
| Oct 11, 2016 | Wallachbeth | Downgrade | Hold | Sell |
| Oct 11, 2016 | Wallachbeth | Downgrade | Buy | Hold |
| Feb 10, 2016 | PiperJaffray | Downgrade | Overweight | Neutral |
| Sep 9, 2014 | PiperJaffray | Initiated | — | Overweight |